down arrow

Biocon

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE376G01013
  • NSEID: BIOCON
  • BSEID: 532523
INR
317.90
12.7 (4.16%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 23.62 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Biocon will declare its result soon on 08 May 2025
stock-summaryPrice Point
High/Low

1Day

313.75322.25

52 Week

260.00404.60
Valuation
Technical
Day's Volume

CASH

23.62 lacs (1.24%) Volume

Shareholding (Dec 2024)

FII

5.66%

Held by 239 FIIs

DII

15.37%

Held by 48 DIIs

Promoter

60.64%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 2.41% of over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 38,167 Cr (Large Cap)

stock-summary
P/E

48.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.16%

stock-summary
Debt Equity

0.67

stock-summary
Return on Equity

6.64%

stock-summary
Price to Book

1.75

Revenue and Profits (1 Year):
Net Sales:
3,821 Cr
(Quarterly Results - Dec 2024)
Net Profit:
25 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.16%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-8.11%
0%
-8.11%
1 Year
14.15%
0.16%
14.31%
2 Years
47.24%
0.82%
48.06%
3 Years
-9.62%
0.76%
-8.86%
4 Years
-24.36%
0.65%
-23.71%
5 Years
-4.69%
0.71%
-3.98%

Latest dividend: 0.5 per share ex-dividend date: Jul-05-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.53%
EBIT Growth (5y)
2.41%
EBIT to Interest (avg)
8.20
Debt to EBITDA (avg)
3.60
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.54
Tax Ratio
30.60%
Dividend Payout Ratio
5.87%
Pledged Shares
0
Institutional Holding
21.02%
ROCE (avg)
9.22%
ROE (avg)
7.29%
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
33
Price to Book Value
1.75
EV to EBIT
38.58
EV to EBITDA
17.07
EV to Capital Employed
1.45
EV to Sales
3.44
PEG Ratio
NA
Dividend Yield
0.16%
ROCE (Latest)
4.28%
ROE (Latest)
6.64%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 29 Schemes (8.58%)

FIIs

Held by 239 FIIs (5.66%)

Promoter with highest holding

Kiran Mazumdar Shaw (40.36%)

Highest Public shareholder

Life Insurance Corporation Of India (5.34%)

Individual Investors Holdings

14.07%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 6.43% vs 4.59% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 256.88% vs -102.43% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,821.40",
          "val2": "3,590.40",
          "chgp": "6.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "751.80",
          "val2": "685.40",
          "chgp": "9.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "223.40",
          "val2": "225.60",
          "chgp": "-0.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "18.10",
          "val2": "26.00",
          "chgp": "-30.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.10",
          "val2": "-16.00",
          "chgp": "256.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.93%",
          "val2": "19.33%",
          "chgp": "0.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 2.01% vs 54.40% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 183.57% vs 18.66% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,023.30",
          "val2": "6,884.90",
          "chgp": "2.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,305.80",
          "val2": "1,456.00",
          "chgp": "-10.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "461.60",
          "val2": "480.70",
          "chgp": "-3.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "58.00",
          "val2": "-24.00",
          "chgp": "341.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "643.70",
          "val2": "227.00",
          "chgp": "183.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.87%",
          "val2": "21.46%",
          "chgp": "-2.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.06% vs 46.46% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -24.60% vs 493.31% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,844.70",
          "val2": "10,838.60",
          "chgp": "0.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,057.60",
          "val2": "2,382.80",
          "chgp": "-13.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "685.00",
          "val2": "747.40",
          "chgp": "-8.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "76.10",
          "val2": "-2.80",
          "chgp": "2,817.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "668.80",
          "val2": "887.00",
          "chgp": "-24.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.97%",
          "val2": "21.98%",
          "chgp": "-3.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 32.05% vs 36.54% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 120.99% vs -28.64% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,755.70",
          "val2": "11,174.20",
          "chgp": "32.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,298.70",
          "val2": "2,511.70",
          "chgp": "31.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "974.40",
          "val2": "419.00",
          "chgp": "132.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.60",
          "val2": "-291.40",
          "chgp": "96.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,022.50",
          "val2": "462.70",
          "chgp": "120.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.24%",
          "val2": "22.48%",
          "chgp": "0.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
3,821.40
3,590.40
6.43%
Operating Profit (PBDIT) excl Other Income
751.80
685.40
9.69%
Interest
223.40
225.60
-0.98%
Exceptional Items
18.10
26.00
-30.38%
Consolidate Net Profit
25.10
-16.00
256.88%
Operating Profit Margin (Excl OI)
19.93%
19.33%
0.60%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 6.43% vs 4.59% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 256.88% vs -102.43% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
7,023.30
6,884.90
2.01%
Operating Profit (PBDIT) excl Other Income
1,305.80
1,456.00
-10.32%
Interest
461.60
480.70
-3.97%
Exceptional Items
58.00
-24.00
341.67%
Consolidate Net Profit
643.70
227.00
183.57%
Operating Profit Margin (Excl OI)
18.87%
21.46%
-2.59%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 2.01% vs 54.40% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 183.57% vs 18.66% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
10,844.70
10,838.60
0.06%
Operating Profit (PBDIT) excl Other Income
2,057.60
2,382.80
-13.65%
Interest
685.00
747.40
-8.35%
Exceptional Items
76.10
-2.80
2,817.86%
Consolidate Net Profit
668.80
887.00
-24.60%
Operating Profit Margin (Excl OI)
18.97%
21.98%
-3.01%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.06% vs 46.46% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -24.60% vs 493.31% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
14,755.70
11,174.20
32.05%
Operating Profit (PBDIT) excl Other Income
3,298.70
2,511.70
31.33%
Interest
974.40
419.00
132.55%
Exceptional Items
-11.60
-291.40
96.02%
Consolidate Net Profit
1,022.50
462.70
120.99%
Operating Profit Margin (Excl OI)
23.24%
22.48%
0.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 32.05% vs 36.54% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 120.99% vs -28.64% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Biocon Ltd. stock-summary
stock-summary
Biocon Ltd.
Large Cap
Pharmaceuticals & Drugs
Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company. The Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in the year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.
Company Coordinates stock-summary
Company Details
20th KM Hosur Road Hebbagodi, Electronic City P O Bangalore Karnataka : 560100
stock-summary
Tel: 91-80-28082808
stock-summary
http://www.biocon.com
stock-summary
co.secretary@biocon.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."